Feasibility Study of the Hemolung Respiratory Assist System

NACompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

July 31, 2010

Study Completion Date

August 31, 2010

Conditions
Hypercapnic Respiratory Failure, COPD
Interventions
DEVICE

Hemolung Respiratory Assist System

Patients meeting the inclusion criteria will be placed on the Hemolung Respiratory Assist System. Patients will be weaned from non-invasive ventilation and then the Hemolung. Hemolung support will be provided for up to 7 days. Follow-up exams will be performed every 15 days until hospital discharge or 30 days from completion of Hemolung therapy, whichever is later.

Trial Locations (1)

122001

Artemis Health Institute, Gurgaon

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Alung Technologies

INDUSTRY

NCT00987740 - Feasibility Study of the Hemolung Respiratory Assist System | Biotech Hunter | Biotech Hunter